Join
Live feed
·
INSIDERFilingvia Quantisnow
Paratek Pharmaceuticals Inc. logo

SEC Form 4: Brenner Randall B. sold $57,615 worth of shares (29,282 units at $1.97) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 324,851 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track PRTK (Paratek Pharmaceuticals Inc.) and more on Quantisnow.